Explore high-resolution target-capture DNA analysis for suspect clonal hematopoiesis in this 44-minute conference talk from the Cancer Genomics Consortium's 2022 Annual Meeting. Delve into the objectives, definitions, and first observations of clonal hematopoiesis, examining large prevalence studies and mutational hierarchies. Learn about hematopoiesis mutations, precision medicine clinics, and the pipeline for analyzing suspect cases. Discover the CHIP target capture panel, relevant genes, and the flow process for analysis. Investigate the implications for cancer and bone marrow failure, as well as ongoing clinical trials. Conclude with a summary, aspirations for future research, and a case study, followed by a Q&A session. Gain valuable insights into this cutting-edge DNA analysis technique and its potential impact on cancer diagnosis and treatment.